<?xml version='1.0' encoding='utf-8'?>
<document id="26959349"><sentence text="Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children's Hospitals." /><sentence text="Polypharmacy is common in hospitalized children in the United States and has been identified as a major risk factor for exposure to potential drug-drug interactions" /><sentence text=" Little is known about the characteristics and prevalence of exposure of pediatric patients to polypharmacy and potential drug-drug interactions in PICUs" /><sentence text="" /><sentence text="Retrospective cohort study using the Pediatric Health Information System database" /><sentence text="" /><sentence text="Forty-two freestanding children's hospitals throughout the United States" /><sentence text="" /><sentence text="A total of 54,549 patients less than 18 years old cared for in PICUs in 2011" /><sentence text=" Patients in neonatal ICUs were not included" /><sentence text="" /><sentence text="PICU patients were on average exposed to 10 distinct drugs each hospital day and to 20 drugs cumulatively during their hospitalization" /><sentence text=" Seventy-five percent of patients were exposed to greater than or equal to one potential drug-drug interaction regardless of severity level, 6% to greater than or equal to one contraindicated potential drug-drug interaction, 69% to greater than or equal to one major potential drug-drug interaction, 57% to greater than or equal to one moderate potential drug-drug interaction, 19% to greater than or equal to one minor potential drug-drug interaction" /><sentence text=" Potential drug-drug interaction exposures were significantly associated with specific diagnoses (p &lt; 0" /><sentence text="001), presence of complex chronic conditions (p &lt; 0" /><sentence text="001), increasing number of total distinct drugs used (p &lt; 0" /><sentence text="001), increasing length of stay in PICU (p &lt; 0" /><sentence text="001), and white race (p &lt; 0" /><sentence text="001)" /><sentence text="" /><sentence text="Many PICU patients are exposed to substantial polypharmacy and potential drug-drug interactions" /><sentence text=" Future research should identify the risk of adverse drug events following specific potential drug-drug interaction exposures, especially the risk of adverse drug events due to multiple potential drug-drug interaction exposures, and determine the probability and magnitude of the actual harm (if any) for each specific potential drug-drug interaction, especially for multiple potential drug-drug interaction exposures" /><sentence text="" /></document>